{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-018524","form_type":"8-K/A","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2024-02-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.557729+00:00","generated_at":"2026-06-05T06:10:59.281410+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"ABVC BioPharma amends convertible note with Lind: imposes $1 floor conversion price","bullets":["Amendment to $1.2M secured convertible note sets conversion floor at $1.00, per Nasdaq requirements.","If conversion price hits floor, company must make cash payment to Lind based on formula (A-B)*C.","Lind also received a 5-year warrant to buy 1M shares at $2/share (unchanged from original).","Note originally issued Nov 17, 2023 for $1M purchase price, $1.2M principal.","Amendment waives any prior events of default under transaction documents."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-018524","json":"https://secwatch.observer/filing/0001213900-24-018524.json","markdown":"https://secwatch.observer/filing/0001213900-24-018524.md","text":"https://secwatch.observer/filing/0001213900-24-018524.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024018524/0001213900-24-018524-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024018524/ea0200878-8ka1_abvcbio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T06:10:59.281410+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a022317aef5466759a288980796ace6aba1a2f2a","claim":"ABVC BIOPHARMA, INC. amended Amendment to Note with Lind Global Fund II, LP valued at Conversion price floor of $1.00; cash payment to Lind if floor price triggered (effective 2023-11-20).","evidence_excerpt":"We are filing this amendment to disclose that due to Nasdaq requirements, the parties entered into an amendment to the Note, pursuant to which the conversion price shall have a floor price of $1.00 (the “Amendment”). Additionally, the Amendment requires the Company to make a cash payment to Lind if in connection with a conversion, the conversion price is deemed to be the floor price.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024018524/0001213900-24-018524-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"Lind Global Fund II, LP"},{"label":"Value","value":"Conversion price floor of $1.00; cash payment to Lind if floor price triggered"},{"label":"Effective","value":"2023-11-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}